What is Lotus Bio-Technology Development Earnings Yield (Joel Greenblatt) %?
Lotus Bio-Technology Development's Enterprise Value for the quarter that ended in Dec. 2017 was $15.61 Mil.
Lotus Bio-Technology Development's EBIT for the trailing twelve months (TTM) ended in Dec. 2017 was $-0.01 Mil. Lotus Bio-Technology Development's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2017 was -4.94%.
The historical rank and industry rank for Lotus Bio-Technology Development's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
LBTD's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Agriculture industry.
Industry Median: 4.645 * Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Lotus Bio-Technology Development's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2017 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Lotus Bio-Technology Development Earnings Yield (Joel Greenblatt) % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Lotus Bio-Technology Development Earnings Yield (Joel Greenblatt) % Chart
For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Bio-Technology Development's Earnings Yield (Joel Greenblatt) % Distribution in the Agriculture Industry
For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Lotus Bio-Technology Development's Earnings Yield (Joel Greenblatt) % falls into.
Lotus Bio-Technology Development Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Lotus Bio-Technology Development's EBIT for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.
Lotus Bio-Technology Development (OTCPK:LBTD) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Lotus Bio-Technology Development Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Lotus Bio-Technology Development's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Lotus Bio-Technology Development (Lotus Bio-Technology Development) Business Description
Lotus Bio-Technology Development Corp is a biotechnology development company. It focuses on specializing in the refining of organic materials and the production of natural consumer-related products. It is exploring opportunities in the organic growth and farming sector in China and provides local customers the real organic food products with affordable prices and guarantees that all of them will be produced in an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones, or other dangerous chemicals. All the operation is primarily functioned through the region of China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LBTD has been successfully added to your 